Replies to post #250609 on Biotech Values

[DewDiligence]

Pharmacosmos—(private)—acquires GTHX for $7.15/sh cash—a 68% premium to yesterday’s close:

https://finance.yahoo.com/news/pharmacosmos-group-acquire-g1-therapeutics-102900391.html

The nominal deal value is $405M.

p.s. I had never heard of Denmark's Pharmacosmos until today.